IWMPD
MIPI

Integrated Wealth Management (Palm Desert)’s MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK MIPI Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio MIPI Stock Details MIPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-700
Closed – – 1391
2016
Q2 		$0 Buy
+700
New – ﹤0.01% 1448

Integrated Wealth Management (Palm Desert)'s MIPI Position: Q3 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK (MIPI) in Q3 2016, closing a stake of 700 shares.

Integrated Wealth Management (Palm Desert) first reported a position in MIPI in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 1 fund tracked by Wall St. Rank holds MIPI as of Q3 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK position as of Q3 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 700 MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK shares in Q3 2016.
  • Integrated Wealth Management (Palm Desert) first reported a position in MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK in Q2 2016 and held it in 1 quarter.
  • Integrated Wealth Management (Palm Desert)'s MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK position peaked at $0 in Q2 2016.
  • 1 fund tracked by Wall St. Rank held MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK as of Q3 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q3 2016, filed 21 Oct 2016.